RIL
ATYR

Rothschild Investment LLC’s aTyr Pharma ATYR Stock Holding History

Rothschild Investment LLC’s Portfolio ATYR Stock Details ATYR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$528 Buy
885
+598
+208% +$391 ﹤0.01% 3251
2026
Q1 		$224 Buy
287
+178
+163% +$150 ﹤0.01% 3287
2025
Q4 		$85 Buy
+109
New +$89 ﹤0.01% 3223
2025
Q3 		– Sell
-90
Closed -$456 – 3265
2025
Q2 		$456 Buy
+90
New +$354 ﹤0.01% 2777

Other funds holding ATYR

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $69.6B AUM 42.52% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Rothschild Investment LLC's ATYR Position: Q2 2026 in Review

Rothschild Investment LLC increased its aTyr Pharma (ATYR) stake by 208% in Q2 2026, buying an estimated $391 and bringing the position to 885 shares worth $528. The position accounts for ﹤0.01% of the portfolio, ranked #3251.

Rothschild Investment LLC first reported a position in ATYR in Q2 2025 and has held it in 4 quarters since. 89 funds tracked by Wall St. Rank hold ATYR as of Q2 2026.

  • Rothschild Investment LLC held 885 shares of aTyr Pharma worth $528 as of Q2 2026.
  • Rothschild Investment LLC bought 598 aTyr Pharma shares in Q2 2026, an estimated $391.
  • aTyr Pharma made up ﹤0.01% of Rothschild Investment LLC's portfolio in Q2 2026, its #3251 holding.
  • Rothschild Investment LLC first reported a position in aTyr Pharma in Q2 2025 and has held it in 4 quarters since.
  • 89 funds tracked by Wall St. Rank held aTyr Pharma as of Q2 2026.

Based on Rothschild Investment LLC's 13F filing for Q2 2026, filed 6 Aug 2026.